A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616] (Q24800133)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Predicting renal outcome in IgA nephropathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

The commonest glomerulonephritis in the world: IgA nephropathy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Worldwide perspective of IgA nephropathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Mycophenolate mofetil treatment for primary glomerular diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Corticosteroids in IgA nephropathy: a randomised controlled trial

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Reduction of proteinuria by angiotensin converting enzyme inhibition

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

IgA nephropathy: long-term prognosis for pediatric patients.

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

Determinants of social outcome measured by the Frenchay Activities Index at one year after stroke onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

Regional cerebral blood flow and prognostic evaluation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=415550

A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study

28 November 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

Mycophenolate mofetil for systemic vasculitis and IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

Successful mycophenolate mofetil treatment of glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-5-3

Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial

21 January 2018

1 reference

12 December 2020

The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group

1 reference

12 December 2020

Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain

1 reference

12 December 2020

ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study

1 reference

12 December 2020

A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group

1 reference

12 December 2020